Oregon § 433.295 Newborn bloodspot screening standards and reporting requirements for health care providers and health care facilities

Oregon Statutes

§ 433.295 — Newborn bloodspot screening standards and reporting requirements for health care providers and health care facilities

Oregon § 433.295

Vol.12

Title 36Public Health and Safety

Ch. 433Disease and Condition Control; Mass Gatherings; Indoor Air

This text of Oregon § 433.295 (Newborn bloodspot screening standards and reporting requirements for health care providers and health care facilities) is published on Counsel Stack Legal Research, covering Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Or. Rev. Stat. § 433.295 (2026).

Text

Health care providers and health care facilities that provide services to infants in Oregon shall:

(1)Ensure that specimens for newborn bloodspot screening are collected and delivered pursuant to rules adopted by the Oregon Health Authority under ORS 433.288;

(2)Ensure that an infant receives medically appropriate care consistent with the results of a newborn bloodspot screening; and

(3)Report to the authority for quality control purposes:

(a)Medical conditions detected by newborn bloodspot screening and subsequently confirmed; and

(b)Medical conditions on the newborn bloodspot screening panel detected by a test other than newborn bloodspot screening.

Free access — add to your briefcase to read the full text and ask questions with AI

Health care providers and health care facilities that provide services to infants in Oregon shall:
(1) Ensure that specimens for newborn bloodspot screening are collected and delivered pursuant to rules adopted by the Oregon Health Authority under ORS 433.288;
(2) Ensure that an infant receives medically appropriate care consistent with the results of a newborn bloodspot screening; and
(3) Report to the authority for quality control purposes:
(a) Medical conditions detected by newborn bloodspot screening and subsequently confirmed; and
(b) Medical conditions on the newborn bloodspot screening panel detected by a test other than newborn bloodspot screening.